|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Unrealized loss from digital assets holdings | |||||
| Deferred tax benefit | |||||
| Writeoff of deferred offering costs | |||||
| Stock based compensation | |||||
| Stock issuance pursuant to services agreement | |||||
| Increase in operating assets: | |||||
| Prepaid expenses and other current assets | |||||
| Increase in operating liabilities: | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of digital assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock upon private investment in public equity offerings | |||||
| Proceeds from issuance of common stock upon at-the-market offering | |||||
| Proceeds from issuance of common stock upon registered direct public offerings | |||||
| Proceeds from issuance of common stock upon cash and cryptocurrency private investment in public equity offering | |||||
| Payment of deferred offering costs | |||||
| Exercise of pre-funded warrants | |||||
| Proceeds from issuance of common stock upon at-the-market offerings | |||||
| Proceeds from exercise of common stock warrants | |||||
| Proceeds from exercise of options | |||||
| Payment of deferred offering costs and other issuance costs | |||||
| Proceeds from insurance premium financing liability | |||||
| Repayment of insurance premium financing liability | |||||
| Repayments of note payable | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
| Cash paid for interest expense | |||||
| Supplemental disclosure of non-cash financing activities: | |||||
| Issuance of common stock for prepaid marketing and investor related consulting services | |||||
| Placement agent warrants as issuance costs of private investment in public equity offerings | |||||
| Amortization of deferred offering costs from ATM offering | |||||
| Reduction of premium related to insurance premium financing | |||||
| Issuance of note payable for settlement of previously incurred professional fees | |||||
| Forgiveness of note payable principal | |||||
| Issuance of options to settle liability | |||||
| Digital assets received in cash and cryptocurrency private investment in public equity offering | |||||
Loading...